Physician profile
Hope Mcintyre
NPI 1538139878
$845.58
in general payments reported to CMS, 2019-2025
7 companies · $18.75 in 2025
The $18.75 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $56.77 · 2021: $170 · 2022: $265 · 2023: $241 · 2024: $93.96 · 2025: $18.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $716.29 | 2020-2024 | Xifaxan |
| Novo Nordisk INC | $47.38 | 2024-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $23.02 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $18.19 | 2021 | |
| Idorsia Pharmaceuticals US INC | $14.09 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $14.05 | 2022 | |
| Paratek Pharmaceuticals, INC. | $12.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Mcintyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.